The nurses assessment of a community dwelling adult suggest that the client may have drug allergies that have not been previously documented. What statements by the client would confirm this? A. I tend to get sick in the stomach when I take antibiotics B. I’ve been told that aspirin might have caused my stomach bleed a few years back C. I broke out in hives and got terribly itchy when I started a new prescription last year D. When I fell last year, the doctor said that it might have been because of my blood pressure pills C. I broke out in hives and got terribly itchy when I started a new prescription last year13.
A. The interview
B. The patient’s medical history
C. The patient’s medical record
D. The patient’s physical examination
E. The patient’s health insurer
A. Knowledge deficit due to the lack of understanding of treatment regimen
B. Coping -ineffective due to forgetfulness
C. Confusion -acute concerning drug administration
D. Anxiety due to diagnosis of hypertension
A. Take their medication with meals
B. Take their medication at the prescribed times
C. Increased medication dosage if necessary
D. Use alternative therapy to increase the effects of their medications
A. Pharmacotherapeutics
B. Pharmacokinetics
C. Pharmacodynamics
D. Pharmacogenetics
A. Drug administration method
B. Core drug knowledge
C. Vital signs of the patient
D. Diagnosis and outcome identification mechanism
A. Call the doctor immediately regarding her allergic reactions
B. Hold the medication for her muscle spasms until she can be treated for a possible allergic reaction
C. Post and allergies notice on the front of her chart and document the allergies in the appropriate area of the electronic medical record
D. Call the dietary staff and make sure that the patient has not served eggs for breakfast
A. Evaluate the outcome of drug therapy
B. Devise strategies to maximize the therapeutic effects of the drug
C. Implement planned nursing actions
D. Assess for data that will indicate interactions between core drug knowledge and core patient variables
A. Compare the outcome expected with the actual patient outcome
B. Reconsider core drug knowledge and core patient variables
C. Ask questions to prepare an effective patient education program
D. Establish a baseline for the patient’s treatment and care
A. Monitor the patient’s bleeding time
B. Check the patient’s blood glucose levels
C. Record baseline vital signs
D. Monitor the IV site for redness, swelling, or pain
A. Heart rate
B. Body weight and height
C. Blood pressure
D. Skin surrounding the potential IV site
A. Have you ever had a bad response to a drug you’ve taken?
B. Does anyone in your immediate family have a history of drug allergies?
C. Are you comfortable with receiving needles?
D. What kind of reactions have you had to medications?
A. I tend to get sick in the stomach when I take antibiotics
B. I’ve been told that aspirin might have caused my stomach bleed a few years back
C. I broke out in hives and got terribly itchy when I started a new prescription last year
D. When I fell last year, the doctor said that it might have been because of my blood pressure pills
A. Focus on learning about a prototype drug that is characteristic of a larger drug class
B. Identify similarities between new drugs and older drugs that are commonly used on the unit
C. Commit time and energy during each shift to learning about new drugs
D. Liaise with pharmacist and pharmacy technicians who work at the hospital
A. Ineffective coping
B. knowledge deficit
C. Acute confusion
D. Anxiety
A. C-I drug
B. C-II drug
C. C-III drug
D. C-IV drug
A. Working with animals who are given experimental drugs
B. Monitoring drug effects in patients who are selected to participate in a study, who may have the disease that the drug is meant to treat
C. Administering investigational drug to patients
D. Informing healthy, young volunteer participants of possible risks that could occur from taking an experimental drug
A. Drugs Facts and Comparisons book
B. A nurse’s drug guide
C. The drug package insert
D. The physicians drug reference (PDR)
A. Narcotics are banned in private settings and cannot be used
B. Narcotics can be used in the hospital after obtaining a written approval from the joint commission for accreditation of hospitals and healthcare organizations (JCAHO)
C. Narcotics to be used in the hospital are dispensed only with a written prescription
D. Narcotics can be used in the hospital according to the patient preferences
A. Provide regular feedback about product safety issues
B. Accredit new medical facilities and hospitals
C. Facilitate the reporting of adverse drug reactions
D. Increase awareness of serious reactions caused by drugs or medical devices
E. Report medication errors that occur in hospitals
C. Facilitate the reporting of adverse reactions of drugs
D. Increase awareness of serious reactions caused by drugs or medical devices
A. Pharmacotherapeutics
B. Pharmacodynamics
C. Pharmacoeconomics
D. Pharmacogenomics
A. A chemical must have proven therapeutic value or efficacy without severe toxicity or damaging properties to become a drug
B. A chemical becomes a drug when it is introduced into the body and causes a change
C. I chemical is considered a drug when the FDA approves it’s released to be marketed
D. A chemical must have demonstrated therapeutic value to become a drug
A. American pharmaceutical association
B. United States adopted names counsel
C. Nursing drug guidelines
D. Federal legislation
A. The drugs chemical names
B. The drugs generic names
C. The drug trade names
D. The drugs biologic names
A. For drug composition
B. The chemical, generic, and trade name of each drug
C. The drug name at least three times-before, during, and after obtaining each drug
D. The cost of each drug
A. There is a potential for confusion and miscommunication if proprietary names are used
B. Proprietary names of drugs can vary from state to state
C. Documentation of trade names for drugs requires permission from the manufacturer
D. Drugs with generic names are prescribed and used differently then proprietary drugs
A. Determining the clinical efficiency and safety of the drug
B. Suggesting potential improvements to the testing process
C. Administering the investigational drug to patients
D. Consulting on the methodology that has been chosen for testing the drug
A. Using an online pharmacy is an excellent way to reduce your drug costs
B. If you do this, make sure that the pharmacy is physically located in the United States
C. Be very careful when doing this, and make sure you’re in close contact with your physician
D. Actually, obtaining prescription drugs via the Internet has recently been made illegal
A. Liability insurance protects nurses from litigation related to drugs
B. Physicians are ultimately responsible for drug errors that occur in hospital settings
C. Nurses have an ethical, but not legal, responsibility to give drugs safely
D. Nurses are legally responsible for safe drug administration
A. additive effect
B. Synergistic effect
C. Potentiated effect
D. Antagonistic effect
A. Allergic reaction
B. Idiosyncratic response
C. Synergistic effect
D. Teratogenic effect
A. The impact of the placebo effect on the patient’s response
B. The accumulative affect of the drug if it is been taken for many years
C. The impact of the warmer climate on the patient’s physical state
D. Problems with patient compliance with the drug regimen due to the move
A. A list of pharmacies where the drug can be obtained
B. Measures to alleviate any discomfort associated with adverse effects
C. The cost of the brand drug compared with the generic form
D. Statistics related to phase III of drug testing for the prescribed drug
A. Infection-risk for related to drug induced bone marrow suppression
B. Nutrition-imbalanced: less than body requirements related to adverse effects of drug
C. Poisoning-risk for related to use of drug with narrow therapeutic index
D. Nutrition-imbalanced: more than body requirements related to adverse effects of drug
A. Increase the serum creatinine level
B. Decrease drug absorption in the blood
C. Decrease the amount of circulating blood sent through the kidneys
D. Increase the synergistic effect of the drug
A. Track the exact route of metabolism as a research project
B. Identify any changes in drug absorption that would change the drug effect
C. Monitor only for the adverse effect of immunotoxicity
D. Determine the speed of chelation
A. Presence of food in the gastrointestinal tract
B. Increase in hepatic enzymes
C. Protein binding
D. High blood levels
A. Hepatotoxic response
B. Idiosyncratic response
C. Paradoxical response
D. Allergic response
A. The man may be experiencing a paradoxical effect of aspirin
B. The man may be allergic to aspirin
C. The man may be experiencing liver toxicity from aspirin
D. The man may be experiencing nephrotoxic effects of aspirin
A. Take their medications with food unless otherwise instructed
B. Consult their care provider before taking new over-the-counter medications
C. Maintain a healthy, high fluid diet, and high levels of physical activity
D. Ensure that there is at least 90 minutes between doses of different drugs
A. Atorvastatin (Lipitor)
B. Rabeprazole (Aciphex)
C. Vitamin D
D. Citalopram (Celexa)
A. The adverse effects of each drug may cancel each other out
B. Using to drugs for a health problem tends to increase patient compliance with the drug regimen
C. Using lower doses of two separate drugs may lessen the risk of adverse reactions
D. Using the two drugs to treat a health problem may create a synergistic effect
A. Warn the patient about the possibility of idiosyncratic drug effects
B. Assess the possibility that the antibiotic is causing the patients nausea
C. Check the compatibility of the two drugs
D. Review the patient’s most recent bloodwork
A. Nonpharmacologic interventions combined with an exercise program
B. Drug therapy with bromocriptine (Parlodel)
C. Aggressive respiratory assistance
D. No nursing action unless the patient experiences a “bad trip”
A. Increased appetite
B. Hypertension
C. Bradycardia
D. Stupor
A. Bradycardia
B. Diarrhea
C. Nausea
D. Slight headache
A. Not long, he should be fine in a few minutes
B. It’s very hard to tell, but seizure activity might not in right away
C. It is possible that the seizure activity could last a week or more
D. Once a person has had a seizure there is always the possibility of other seizures
A. Retarded absorption from the small intestine
B. Immediate distribution at the rate proportional to blood flow and water content
C. Metabolism using the enzyme alcohol dehydrogenase
D. Deficiency in the enzyme aldehyde dehydrogenase
A. Blood pressure: 98/50, pulse: 120, respirations: 40
B. Blood pressure: 130/88, pulse: 92, respirations: 28
C. Look pressure: 150/90, pulse: 80, respirations: 16
D. Blood pressure: 170/98, pulse: 110, respirations: 20
A. Methamphetamine
B. Cocaine
C. Marijuana
D. Nicotine
A. Administer epinephrine
B. Administer oxygen therapy
C. Provide and emesis basin
D. Assess the patient’s psychosocial status
A. Low self-esteem
B. Divorced parents
C. Financial problems
D. Health concerns
E. Depression
B. Divorced parents
E. Depression
A. Amphetamines
B. Sedative-hypnotic drugs
C. Benzodiazepines
D. Opioids
A. Drug tolerance
B. Addiction
C. Dependence
D. Withdrawal
A. Assessing the patients pattern of dependence and coping strategies
B. Assessing Neurological status and assessing for electrolyte in balances
C. Assessing for Impaired nutrition
D. Assessing for possible interactions between alcohol and other drugs
A. Hypokalemia or hyponatremia
B. Acute gastrointestinal bleed
C. Increased intracranial pressure
D. Respiratory depression
A. Most people don’t know that marijuana can be just as addictive as heroin or cocaine overtime
B. Marijuana can easily interact with other drugs and cause potentially fatal reactions
C. Every year, thousands of Americans end up in emergency rooms with marijuana overdoses
D. Smoking marijuana is just as bad, or worse, for your lungs and smoking cigarettes
A. Changes in blood chemistry as a result of nephrotoxicity and hepatotoxicity
B. Impaired maternal nutrition as a result of drug use
C. Vasoconstriction leading to reduced placental blood flow
D. Hypoxia as a result of prolonged second stage of labor
A. Tuberculosis
B. Malaria
C. Diabetes
D. Hypertension
A. Exhibit no change in metabolic activity through the CYP2D6 pathway
B. Metabolize drugs poorly through the CYP2D6 pathway
C. Exhibit reduced CYP2D6 activity
D. Exhibit ultra-rapid metabolism through the CYP2D6 pathway
A. Patients father
B. The patient’s spouse
C. The patients grandmother
D. The patients grandfather
A. Analgesics
B. Diuretics
C. Ginseng
D. Antidepressants
A. Body language to educate her and then give her the discharge instructions
B. An interpreter to educate her and then give her the English version of the discharge instructions, so she can begin to learn the language
C. A translator to translate the material and give them to her
D. An interpreter to review the discharge instructions with the patient and then give her the printed material translated into Spanish
A. A higher-than-normal dose of drugs that bind to acid glycoproteins
B. A lower-than-normal dose of drugs that bind to acid glycoproteins
C. They recommended normal dose of drugs that bind to acid glycoproteins
D. One half the recommended dose of drugs that bind to acid glycoproteins
A. Speak loudly
B. Exaggerate her mouth movements
C. Use nonverbal language
D. Speak fast
A. I’m sorry, but that will not be possible
B. I will need to inform the doctor and see if he will allow this
C. As long as the ritual does not interfere with the patients preoperative care, it will be OK
D. I don’t think that will help, but you have the right to perform the ritual
A. Ensure that the woman receive care solely from Spanish-speaking caregivers
B. Consider dimensions of the woman’s cultural background when planning care
C. Integrate teaching about American culture when interacting with the patient
D. Address the woman’s children first when explaining her care and changes in her health status
A. How can we integrate cultural beliefs and preferences into drug therapy?
B. How can we use pharmaceuticals in an effort to improve the human genome?
C. How can we best treat the diseases that are known to be more prevalent in certain groups?
D. How can we customize drugs to be especially effective for particular individuals and groups?
A. Genotype is an expression of DNA, but phenotype is a cultural concepts
B. Genotype is easily modifiable, but phenotype is not modifiable
C. Genotype is a consequence of the genetic makeup of an individual’s parents while phenotype is unique to every individual
D. Genotype is the composition of a person’s DNA, but phenotype is the manifestation of these genes
A. Excretion
B. Distribution
C. Metabolism
D. Absorption
A. Hypertension
B. Low bone density
C. A seizure disorder
D. Cardiac arrhythmias
A. A 47-year-old woman with hypertension
B. A 52-year-old man with adult onset diabetes
C. A 17-year-old girl with symptoms of an upper respiratory infection
D. 62-year-old man with gout
A. Weigh the patient to get the correct body surface area
B. Had a second nurse check the dance before administering the drug
C. Question the order because the patient is not receiving any other antihypertensives
D. Make sure the patient is on a cardiac monitor
A. I may have a very dry mouth while taking this drug
B. I should never stop taking this drug abruptly
C. I can stop walking a mile a day
D. Since I am taking this drug, I no longer need to worry about my diet
A. Assess heart rate
B. Check blood glucose level
C. Measure urine output
D. Monitor respiratory rate
A. Take his pulse at least four times a day
B. Wait himself once a week at the same time of the day
C. Avoid smoke-filled rooms
D. Understand the signs and symptoms of hypoglycemia
A. Pain and swelling around the sting site
B. Discoloration in her hand
C. Acute anxiety
D. Acute bronchospasm
A. Decrease heart rate
B. Decrease blood pressure
C. Increase blood pressure
D. Increase body temperature
A. Imbalance nutrition: less than body requirements
B. Disturbed sleep pattern, insomnia related to CNS excitation
C. Disturbed sensory perception
D. Ineffective tissue perfusion
A. Take two doses when the next dose is due at 2 PM
B. Take two doses as soon as possible
C. Take the missed dose as soon as possible
D. Skip the missed dose and return to the regular dose at 2 PM
A. Peptic ulcer disease
B. History of Acute myocardial infarction
C. Diabetes mellitus
D. Obesity
A. An adrenergic antagonist
B. An adrenergic agonist
C. A cardiotonic
D. A neurotransmitter
A. Respiratory assessment
B. Arterial blood gases
C. Monitoring of intracranial pressure
D. Cardiac monitoring
A. Uptake of acetylcholine
B. Dopamine receptors in the brain
C. Synthesis of epinephrine
D. Sensitivity of beta-2 receptors
A. Oxygen saturation and respiratory rate
B. Heart rate and blood pressure
C. Level of consciousness and pain level
D. Temperature and respiratory rate
A. A cloudy appearance in the IV line with infusion
B. Burning and redness at the IV site
C. Increased blood loss intraoperatively
D. A pH change and inactivation of the antibiotic
A. Every medication should be taken with food to reduce adverse effects from the drug
B. Gastric emptying can occur as soon as 10 minutes after the meal, and he can take the medications then
C. Many medications are in active if the pH in the stomach is too high and prevents excretion
D. Food can delay or reduce the absorption of oral drugs, and some require an empty stomach to facilitate absorption
A. Morphine and antidepressants
B. Morphine and Pepcid
C. Morphine and Percocet
D. Morphine and tobacco use
A. Polypharmacy
B. Major adverse drug interactions
C. Overuse of over-the-counter medications
D. Inappropriate prescriptions
A. Reassess the blood pressure before giving the medication
B. Instruct the patient that the medication is for blood pressure
C. Question the order that the patient takes her medications
D. Teach the patient to take the medication in the morning since it contains a diuretic
A. Alger Hiss act
B. Ryan Haight act
C. James Zardroga Act
D. Volstead ctA
A. The patient is not following the dosing, which is causing the side effects
B. The patient is purchasing drugs from two different pharmacies and getting different concentrations
C. The drugs are interacting and potentiating the anti-cholinergic side effects
D. The drugs should not be prescribed simultaneously and are counteracting each other
A. Education about herbals is not within the scope of the APN
B. Herbals are harmless and safe to use because they are made from plants
C. Herbals can have interactions with prescribed medications
D. Herbals or researched and approved by the FDA
A. Utilizing the teacher-back method to ensure the patient is understanding in his situation
B. Meeting the needs of the patient before providing education
C. Giving written medication information so the patient can look it over when they feel better
D. Involving family members that are symptom-free who can easily learn about the medications
A. Peer
B. Drug dealers
C. Family members
D. Strangers
A. Pain relievers
B. Sedatives
C. Tranquilizers
D. Stimulants
A. Levaquin
B. Omnicef
C. Bactrim
D. Augmentin
A. Yes, but the healthcare team will monitor for any side effects
B. Yes, all medications have side effects
C. Yes, let me talk with you about those side effects
D. Why do you ask?
A. The federal drug administration
B. The manufacturer
C. The national pharmacy chain
D. National drug distributor
A. Identifying potential and actual drug related problem
B. Resolving actual drug related problem
C. Preventing potential drug related problem
D. Monitoring drug related problem
A. A patient has to purchase generic ibuprofen because Advil is unavailable
B. A patient dies from sepsis since there is no antibiotic sensitive to an identified pathogen
C. A woman has a miscarriage because RhoGAM is unavailable
D. Lisinopril is substituted for Prinivil because Prinivil is unavailable from any manufacture
A. Warfarin
B. Metoprolol
C. Ibuprofen
D. Acetaminophen
A. medication that is non-FDA approved
B. Receiving substandard medication
C. Delay in receiving medication
D. Increased possibility of counterfeit medication
A. He is responsible to pay for the Actos out-of-pocket
B. He should be switched from Actos to Actiq since it is less expensive and more efficacious
C. There is no change in medication usage because Medicare part D covers his prescriptions
D. He must wait for approval from his insurance company before filling his prescription
A. Xopenex is a new drug, and many insurance companies are not for familiar with it
B. Outcomes for the two drugs are the same and therefore the increased cost is not justified
C. Insurance companies are concerned with the excessive cost since asthma is very common
D. Xopenex has a higher incidence of allergic reactions, which increases cost of coverage
A. And APN is asked by a physician in the same practice to research the quality-of-life measures for two of the most popular drugs prescribed for rheumatoid arthritis. The physician would like to know how drug A compares to drug B from anecdotal evidence of patients who have used H, specifically qualitative measures regarding how much the patient’s quality of life has improved after six months of therapy on each drug.
B. And APN is asked by the physician in the same practice to research the biochemical method by which a certain anti-emetic drug (Drug A) works, compared to another drug (drug B) whose off-label use would be as an anti-nausea medication. The APN is asked to provide a side-by-side comparison of all possible contraindications of each drug
C. And APN is collaborating with hospital administrators to help decide what chemotherapy drug should be on the formulary. Drug A is well tolerated, effective, and expensive. Drug B is also effective, but has more side effects, and is significantly less expensive. The administrators have asked the APN to research data supporting the additional cost of drug A.
D. And APN is asked by a patient for a comparison of birth control pill A with birth control pill B. Specifically, the patient would like to know the side effects of each pill, as well as how often each must be taken, and the efficacy of each at preventing pregnancy.
A. Over-the-counter cold medications
B. Antibiotic for sinus infection
C. Albuterol SVN
D. Daily fiber supplements
E. Racemic epi SVN
C. Albuterol SVN
A. One amp of D50
B. IV normal saline bolus
C. Lactated ringer’s IV bolus
D. Glucagon
E. Insulin
F. Kayexalate
G. Potassium
E. Insulin
G. Potassium
A. Hypnotism
B. Bier Block and Toradol
C. The first surgery until patient can be screened for drug abuse
D. PO Tylenol
A. Metoprolol
B. Niacin
C. Oxygen therapy
D. Incentive Spirometry
A. Communication only with the patient is imperative to agree on a plan of care
B. Education, communication, and planning with a designated caregiver are key
C. Institutionalization is the next step to safely manage this patient’s disorder and medications
D. The patient’s medications need to be discontinued because of the patient’s poor memory and increased risk of overdose
A. If the patient has a fast heart rate and trembling after an injection, the patient should consider epinephrine as an allergy
B. Two doses of the EpiPen should be used
C. The patient should never self-administer the EpiPen
D. The EpiPen should be used even if it’s expired
A. Chronic inotropes and heart transplant
B. IV potassium and calcium channel blocker
C. Hemodialysis
D. Physical therapy
A. The prescriber does not have to report the adverse event to MedWatch since no permanent damage or death resulted
B. No specific member of the healthcare team is responsible to report, as participation in MedWatch is voluntary
C. The prescriber is legally responsible to report adverse event to MedWatch
D. Any licensed practitioner who cares for the patient is legally responsible to verify that the event was reported to MedWatch
A. Alert the FDA so legal action can be taken against Janssen
B. Alert the FDA and begin to dilute the concentration of Doxil on hand so the supply will last longer
C. Report the shortage to the FDA so underlying cause for shortage can be addressed
D. Alert the FDA so production of the drug can be increased
A. Communication between patients and providers
B. Communication between the FDA and the White House
C. Communication between the public and the FDA
D. Communication between the Surgeon General and the FDA
A. To inform patients about purchasing their own supply of drugs in short supply
B. To address drug shortages that have a significant impact on public health
C. To oversee manufacturing and shortage of drugs made in the United States
D. To oversee pricing of drugs being manufactured and sold in the United States
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
E. Phase V
A. Federal drug administration
B. Mainstream media sources
C. Physicians desk reference
D. Center for disease control
A. Category A
B. Category B
C. Category C
D. Category D
E. Category E
A. Termination of the war on illicit drugs
B. escalation of the war on the illicit drugs
C. Maintenance of the war on illicit drugs
D. De-escalation of the war on illicit drugs
A. All prescription medications
B. All controlled substance prescriptions
C. All narcotic prescription medications
D. All scheduled C-II and scheduled C-III prescriptions
A. Defers the decision for monitoring controlled substances to pharmacists
B. Defers the decision for monitoring controlled substances to individual prescribers
C. Defers the decision for monitoring controlled substances to each state
D. Requires each state to have a controlled substance monitoring program
A. The state through the board of medicine
B. The state through legislative authority
C. The federal government
D. The state through the board of nursing
A. To acknowledge the advanced training and education of nurse practitioners
B. To allow nurse practitioners to practice in a variety of settings
C. To provide comprehensive healthcare services
D. To encourage equality with physician counterparts
A. Inquire to the parents of the patient about possible source of marijuana
B. Discourage the patient from participating in sports until he is a nonuser
C. Recommend inpatient treatment to prevent further substance abuse
D. Know the youth prevention-related measures to decrease the risk of escalation of abuse
A. The nurse should tell the patient that you will detect any drugs in the system at the next physical to prevent them from experimenting with drugs
B. The nurse should not approach the subject of substance abuse unless the patient has physical signs of abuse
C. The nurse should try to elicit information from all school aged patients regardless of the patient’s age or appearance
D. The nurse should instruct the school guidance counselor to address the topic as it is not the role of the provider to discuss substance abuse
A. The combination of the drugs can have a drug effects opposite of the desired effect, creating worst heartburn
B. The Tums speed up the rate of digestion preventing the body from absorbing the Benadryl
C. The Tums increased the pH in the stomach, which decreases the ionization of-based drugs, resulting in a decrease drug effect
D. The Tums lower the pH in the stomach and increase ionization of base drugs, resulting in a decreased drug effect
A. Inform the client that the herbal treatments will be ineffective
B. Obtain more information and determine whether herbs are compatible with medications prescribed
C. Notify the healthcare provider immediately
D. Inform the client that the healthcare provider will not treat him if he does not accept the use of traditional medicine only
A. Man seek healthcare earlier than women
B. Women may not seek treatment for cardiac conditions as quickly as men
C. Women are more likely to stop taking medications because of side effects
D. All drug trials are conducted on male subjects
A. Irrelevant because medications at on scientific principles
B. Important to the client acceptance of medical treatment and response to treatment
C. Harmless if it makes the client feel better
D. Harmful, especially if treatment is delayed
A. They are more prone to drug toxicity
B. They may require more time to absorb you enteral medications
C. They must be given liquid medications only
D. They should be advised to decrease protein intake
A. Herbal products are natural and poses no risk to the client but may be costly
B. Herbal products are welcome supplements to conventional medications but do not always come with instructions
C. The client may be at risk for allergic reactions
D. The herbal products may interact with prescribed medications and affect drug action
A. Insomnia
B. Urinary problems associated with prostate enlargement
C. Symptoms of menopause
D. Urinary tract infection
A. Absence of edema in the lower extremities
B. Weight loss of 6 pounds
C. Blood pressure log notes blood pressure 120 over 70 mmHg to 134/80 8 mmHg since discharge
D. Frequency avoiding of at least six times per day
A. Rash and chills
B. Reflex tachycardia
C. Increased urinary output
D. Weight loss
A. The blood pressure will decrease faster
B. Lower doses of those drugs may be given with fewer adverse effects
C. There is less daily medication dosing
D. Combination therapy will treat the patients other medical conditions
A. Increase fluids and fiber to prevent constipation
B. Report a weight gain of 1 kg per month or more
C. Immediately stopped taking the medication if sexual dysfunction occurs
D. Rise slowly after prolonged periods of sitting or lying down
A. Reflex hypertension
B. Hyperkalemia
C. Persistent cough
D. Angioedema
E. Hypotension
C. Persistent cough
D. Angioedema
E. Hypotension
A. Giving the two drugs together will lower the blood pressure even more than just with one alone
B. The hydralazine may cause tachycardia and the propanolol will help keep the heart rate within normal limits.
C. The propanolol is to prevent lupus erythematosus from developing
D. Direct-acting vasodilators such as hydralazine cause fluid retention and the propanolol will prevent excessive fluid buildup
A. Swallow three tablets immediately for pain and call 911
B. Put one tablet under your tongue for chest pain. If pain does not subside, you May repeat in five minutes, taking no more than three tablets
C. Call your healthcare provider when you have chest pain. He will tell you how many tablets to take
D. Place three tablets under your tongue and call 911
A. Keep the patches in the refrigerator
B. Use the patches only if the chest pain is severe
C. Remove the old patch before applying a new one
D. Apply the patch only to the upper arm or thigh areas
A. Heart rate of 50 bpm
B. Heart rate of 124 bpm
C. Blood pressure 86/56
D. Blood pressure 156/88
E. Tinnitus and vertigo
C. Blood pressure 86/56
A. Flushing and headache
B. Tremors and anxiety
C. Sleepiness and lethargy
D. Light-headedness and dizziness
A. They contain nitrates, resulting in an overdose
B. They decreased blood pressure and may result in prolonged and severe hypotension when combined with nitrates
C. They will adequately treat the patients angina as well as erectile dysfunction
D. They will increase the possibility of nitrate tolerance developing and should be avoided unless other drugs can be used
A. Use the albuterol inhaler, and used a beclomethasone only if symptoms are not relieved
B. Use the beclomethasone inhaler, and use the albuterol only if symptoms are not relieved
C. Use the albuterol inhaler, wait 5-10 minutes, then use the beclomethasone inhaler
D. Use the beclomethasone inhaler, wait 5-10 minutes, then use the albuterol inhaler
A. The client has been consuming hot beverages after the use of his inhaler
B. The client has limited his fluid intake, resulting in dry mouth
C. The residue of the inhaler propellant is coating the inside of his mouth
D. The client has developed thrush as a result of the fluticasone
A. The nurse will teach the patient to recognize and respond to adverse effects from the medication
B. The patient will demonstrate self administration of the medication, using a preloaded syringe into the subcutaneous tissue of the thigh, prior to discharge
C. The nurse will teach the patient to accurately prepare a dose of medication
D. The patient will be able to self manage his disease and medications
A. The patients promise to comply with the drug therapy
B. The patient satisfaction with the drug
C. The cost of the medication
D. Evidence of therapeutic benefit from the medication
A. Atelectasis
B. Crystalluria
C. Photosensitivity
D. Orthostatic hypotension
A. Monitor for the presence or absence of bowel sounds
B. Obtain urine samples for specific gravity measurements and glucose levels
C. Observe skin pressure points for turgor and integrity
D. Titrate intravenous infusion rate according to the blood-pressure response
A. They reported allergy to peanuts
B. A history of intolerance to albuterol (Proventil, VoSpire)
C. A history of bronchospasms
D. I reported allergy to chocolate
A. Whether the patient received adequate teaching related to her medication and expresses an understanding of the teaching
B. Whether the patient was encouraged to skip her medication by a family member or friend
C. Whether the patient is old enough to understand the consequences of her actions
D. Whether the provider will write another prescription because the patient refused to take medication the first time
A. Providing detailed written information when the client is discharged
B. Providing the patient with Internet links to conduct research on drugs
C. Referring the patient to external health care groups they provided patient education, such as the American Heart Association
D. Providing education about the patient’s medication each time the nurse administers the drugs
A. Avoid hot baths and showers, and prolonged standing in one position
B. This drug make this color the urine a pinkish-brown color
C. You may experience bloating and Weight gain
D. The tablet be should taken only with food or milk

For any questions, feedback, or comments, we have an ethical customer support team that is always waiting on the line for your inquiries.